<?xml version="1.0" encoding="UTF-8" standalone="no"?><!--IFIndAs V2.1 (26-06-2026)--><xbrli:xbrl xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:in-capmkt="http://www.sebi.gov.in/xbrl/2026-01-31/in-capmkt" xmlns:in-capmkt-ent="http://www.sebi.gov.in/xbrl/IntegratedFinance_IndAS/2026-01-31/in-capmkt/in-capmkt-ent" xmlns:in-capmkt-roles="http://www.sebi.gov.in/xbrl/IntegratedFinance_IndAS/2026-01-31/in-capmkt-roles" xmlns:in-capmkt-types="http://www.sebi.gov.in/xbrl/2026-01-31/in-capmkt-types" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:net="http://www.xbrl.org/2009/role/net" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink"><link:schemaRef xlink:href="in-capmkt-ent-2026-01-31.xsd" xlink:type="simple"/><xbrli:context id="OneD"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="OneI"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="PY_I"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="FourD"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="OneExpenses1D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:DetailsOfOtherExpensesAxis">in-capmkt:OtherExpenses1Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="OneExpenses2D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:DetailsOfOtherExpensesAxis">in-capmkt:OtherExpenses2Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="OneExpenses3D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:DetailsOfOtherExpensesAxis">in-capmkt:OtherExpenses3Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="FourExpenses1D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:DetailsOfOtherExpensesAxis">in-capmkt:OtherExpenses1Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="FourExpenses2D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:DetailsOfOtherExpensesAxis">in-capmkt:OtherExpenses2Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="FourExpenses3D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:DetailsOfOtherExpensesAxis">in-capmkt:OtherExpenses3Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="I_OtherNoncurrentAssets1"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:OtherNoncurrentAssetsAxis"><in-capmkt:OtherNoncurrentAssetsDomain>OtherNoncurrentAssetsDomain1</in-capmkt:OtherNoncurrentAssetsDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_OtherCurrentAssets1"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:OtherCurrentAssetsAxis"><in-capmkt:OtherCurrentAssetsDomain>OtherCurrentAssetsDomain1</in-capmkt:OtherCurrentAssetsDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_OtherCurrentAssets2"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:OtherCurrentAssetsAxis"><in-capmkt:OtherCurrentAssetsDomain>OtherCurrentAssetsDomain2</in-capmkt:OtherCurrentAssetsDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_OtherCurrentAssets3"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:OtherCurrentAssetsAxis"><in-capmkt:OtherCurrentAssetsDomain>OtherCurrentAssetsDomain3</in-capmkt:OtherCurrentAssetsDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_OtherCurrentLiabilities1"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:OtherCurrentLiabilitiesAxis"><in-capmkt:OtherCurrentLiabilitiesDomain>OtherCurrentLiabilitiesDomain1</in-capmkt:OtherCurrentLiabilitiesDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_OtherCurrentLiabilities2"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:OtherCurrentLiabilitiesAxis"><in-capmkt:OtherCurrentLiabilitiesDomain>OtherCurrentLiabilitiesDomain2</in-capmkt:OtherCurrentLiabilitiesDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="OneReportable1D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentsAxis">in-capmkt:ReportableSegments1Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="OneReportable2D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentsAxis">in-capmkt:ReportableSegments2Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="FourReportable1D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentsAxis">in-capmkt:ReportableSegments1Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="FourReportable2D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentsAxis">in-capmkt:ReportableSegments2Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="OneReportableFinance1D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentsFinanceCostsAxis">in-capmkt:ReportableSegments1Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="OneReportableFinance2D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentsFinanceCostsAxis">in-capmkt:ReportableSegments2Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="FourReportableFinance1D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentsFinanceCostsAxis">in-capmkt:ReportableSegments1Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="FourReportableFinance2D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-04-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentsFinanceCostsAxis">in-capmkt:ReportableSegments2Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="OneReportable31D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentAssetsAxis">in-capmkt:ReportableSegments1Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="OneReportable31I"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentAssetsAxis">in-capmkt:ReportableSegments1Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="OneReportable32D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentAssetsAxis">in-capmkt:ReportableSegments2Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="OneReportable32I"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentAssetsAxis">in-capmkt:ReportableSegments2Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="OneReportable41D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentLiabilitiesAxis">in-capmkt:ReportableSegments1Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="OneReportable41I"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentLiabilitiesAxis">in-capmkt:ReportableSegments1Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="OneReportable42D"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentLiabilitiesAxis">in-capmkt:ReportableSegments2Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="OneReportable42I"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:explicitMember dimension="in-capmkt:ReportableSegmentLiabilitiesAxis">in-capmkt:ReportableSegments2Member</xbrldi:explicitMember></xbrli:scenario></xbrli:context><xbrli:context id="D_RelatedPartyTransaction1"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain1</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_RelatedPartyTransaction_PY1"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain1</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_RelatedPartyTransaction1"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain1</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_RelatedPartyTransaction2"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain2</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_RelatedPartyTransaction_PY2"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain2</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_RelatedPartyTransaction2"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain2</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_RelatedPartyTransaction3"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain3</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_RelatedPartyTransaction_PY3"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain3</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_RelatedPartyTransaction3"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain3</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_RelatedPartyTransaction4"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain4</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_RelatedPartyTransaction_PY4"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain4</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_RelatedPartyTransaction4"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain4</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_RelatedPartyTransaction5"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain5</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_RelatedPartyTransaction_PY5"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain5</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_RelatedPartyTransaction5"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain5</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_RelatedPartyTransaction6"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain6</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_RelatedPartyTransaction_PY6"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain6</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_RelatedPartyTransaction6"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain6</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="D_RelatedPartyTransaction7"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-07-01</xbrli:startDate><xbrli:endDate>2026-09-30</xbrli:endDate></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain7</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_RelatedPartyTransaction_PY7"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-06-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain7</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:context id="I_RelatedPartyTransaction7"><xbrli:entity><xbrli:identifier scheme="http://www.sebi.gov.in/in-capmkt/Symbol">BIOFILCHEM</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2026-09-30</xbrli:instant></xbrli:period><xbrli:scenario><xbrldi:typedMember dimension="in-capmkt:RelatedPartyTransactionAxis"><in-capmkt:RelatedPartyTransactionDomain>RelatedPartyTransactionDomain7</in-capmkt:RelatedPartyTransactionDomain></xbrldi:typedMember></xbrli:scenario></xbrli:context><xbrli:unit id="INR"><xbrli:measure>iso4217:INR</xbrli:measure></xbrli:unit><xbrli:unit id="INRPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:INR</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><in-capmkt:ScripCode contextRef="OneD">524396</in-capmkt:ScripCode><in-capmkt:Symbol contextRef="OneD">BIOFILCHEM</in-capmkt:Symbol><in-capmkt:MSEISymbol contextRef="OneD">NOTLISTED</in-capmkt:MSEISymbol><in-capmkt:ISIN contextRef="OneD">INE829A01014</in-capmkt:ISIN><in-capmkt:NameOfTheCompany contextRef="OneD">BIOFIL CHEMICALS &amp; PHARMACEUTICALS LIMITED</in-capmkt:NameOfTheCompany><in-capmkt:TypeOfCompany contextRef="OneD">Main Board</in-capmkt:TypeOfCompany><in-capmkt:ClassOfSecurity contextRef="OneD">Equity</in-capmkt:ClassOfSecurity><in-capmkt:DateOfStartOfFinancialYear contextRef="OneD">2026-04-01</in-capmkt:DateOfStartOfFinancialYear><in-capmkt:DateOfEndOfFinancialYear contextRef="OneD">2027-03-31</in-capmkt:DateOfEndOfFinancialYear><in-capmkt:DateOfBoardMeetingWhenFinancialResultsWereApproved contextRef="OneD">2026-11-14</in-capmkt:DateOfBoardMeetingWhenFinancialResultsWereApproved><in-capmkt:DateOnWhichPriorIntimationOfTheMeetingForConsideringFinancialResultsWasInformedToTheExchange contextRef="OneD">2026-11-03</in-capmkt:DateOnWhichPriorIntimationOfTheMeetingForConsideringFinancialResultsWasInformedToTheExchange><in-capmkt:DescriptionOfPresentationCurrency contextRef="OneD">INR</in-capmkt:DescriptionOfPresentationCurrency><in-capmkt:LevelOfRounding contextRef="OneD">Lakhs</in-capmkt:LevelOfRounding><in-capmkt:TypeOfReportingPeriod contextRef="OneD">Quarterly</in-capmkt:TypeOfReportingPeriod><in-capmkt:ReportingQuarter contextRef="OneD">Second quarter</in-capmkt:ReportingQuarter><in-capmkt:IsCompanyReportingMultisegmentOrSingleSegment contextRef="OneD">Multi segment</in-capmkt:IsCompanyReportingMultisegmentOrSingleSegment><in-capmkt:DateOfStartOfBoardMeeting contextRef="OneD">2026-11-14</in-capmkt:DateOfStartOfBoardMeeting><in-capmkt:StartTimeOfBoardMeeting contextRef="OneD">16:30:00</in-capmkt:StartTimeOfBoardMeeting><in-capmkt:DateOfEndOfBoardMeeting contextRef="OneD">2026-11-14</in-capmkt:DateOfEndOfBoardMeeting><in-capmkt:EndTimeOfBoardMeeting contextRef="OneD">17:30:00</in-capmkt:EndTimeOfBoardMeeting><in-capmkt:WhetherCashFlowStatementIsApplicableOnCompany contextRef="OneD">true</in-capmkt:WhetherCashFlowStatementIsApplicableOnCompany><in-capmkt:TypeOfCashFlowStatement contextRef="OneD">Cash Flow Indirect</in-capmkt:TypeOfCashFlowStatement><in-capmkt:DeclarationOfUnmodifiedOpinionOrStatementOnImpactOfAuditQualification contextRef="OneD">Not applicable</in-capmkt:DeclarationOfUnmodifiedOpinionOrStatementOnImpactOfAuditQualification><in-capmkt:WhetherTheCompanyHasAnyRelatedParty contextRef="OneD">true</in-capmkt:WhetherTheCompanyHasAnyRelatedParty><in-capmkt:WhetherTheCompanyHasEnteredIntoAnyRelatedPartyTransactionDuringThePeriod contextRef="OneD">true</in-capmkt:WhetherTheCompanyHasEnteredIntoAnyRelatedPartyTransactionDuringThePeriod><in-capmkt:WeDeclareThatTheAcceptanceOfFixedDepositsByTheBanksOrNonBankingFinanceCompanyAreAtTheTermsUniformlyApplicableOrOfferedToAllShareholdersOrPublic contextRef="OneD">NA</in-capmkt:WeDeclareThatTheAcceptanceOfFixedDepositsByTheBanksOrNonBankingFinanceCompanyAreAtTheTermsUniformlyApplicableOrOfferedToAllShareholdersOrPublic><in-capmkt:WeDeclareThatTheScheduledCommercialBankAsPerRBICircularRBIDBR20151619Dated03March2016HasAllowedAdditionalInterestOfOnePerCentPerAnnumOverAndAboveTheRateOfInterestMentionedInTheScheduleOfInterestRatesOnSavings contextRef="OneD">NA</in-capmkt:WeDeclareThatTheScheduledCommercialBankAsPerRBICircularRBIDBR20151619Dated03March2016HasAllowedAdditionalInterestOfOnePerCentPerAnnumOverAndAboveTheRateOfInterestMentionedInTheScheduleOfInterestRatesOnSavings><in-capmkt:WhetherTheCompanyIsAHighValueDebtListedEntityAccordingTo1AOfRegulation15 contextRef="OneI">false</in-capmkt:WhetherTheCompanyIsAHighValueDebtListedEntityAccordingTo1AOfRegulation15><in-capmkt:WhetherTheUpdatedRelatedPartyTransactionsPolicyHasBeenUploadedOnTheWebsiteOfTheCompanyInComplianceWithRegulation23 contextRef="OneD">true</in-capmkt:WhetherTheUpdatedRelatedPartyTransactionsPolicyHasBeenUploadedOnTheWebsiteOfTheCompanyInComplianceWithRegulation23><in-capmkt:LatestDateOnWhichRelatedPartyTransactionsPolicyIsUpdated contextRef="OneD">2025-02-11</in-capmkt:LatestDateOnWhichRelatedPartyTransactionsPolicyIsUpdated><in-capmkt:WebsiteLinkForUpdatedRelatedPartyTransactionsPolicyOfTheCompany contextRef="OneD">https://mufmerinmovawwcvpkjx.supabase.co/storage/v1/object/public/investor_documents/investor_documents/Policy%20on%20dealing%20with%20related%20party%20transactions_11.02.2025.pdf</in-capmkt:WebsiteLinkForUpdatedRelatedPartyTransactionsPolicyOfTheCompany><in-capmkt:WhetherStatementOnDeviationOrVariationForProceedsOfPublicIssueOrRightIssueOrPreferentialIssueOrQIPEtcIsApplicableToTheCompanyForTheCurrentQuarter contextRef="OneD">false</in-capmkt:WhetherStatementOnDeviationOrVariationForProceedsOfPublicIssueOrRightIssueOrPreferentialIssueOrQIPEtcIsApplicableToTheCompanyForTheCurrentQuarter><in-capmkt:WhetherTheDisclosureForTheDefaultOnLoansAndDebtSecuritiesIsApplicableToTheEntity contextRef="OneD">false</in-capmkt:WhetherTheDisclosureForTheDefaultOnLoansAndDebtSecuritiesIsApplicableToTheEntity><in-capmkt:NoteForNonApplicabilityOfTheDisclosureForTheDefaultOnLoansAndDebtSecuritiesToTheEntity contextRef="OneD">NA</in-capmkt:NoteForNonApplicabilityOfTheDisclosureForTheDefaultOnLoansAndDebtSecuritiesToTheEntity><in-capmkt:DateOfStartOfReportingPeriod contextRef="OneD">2026-07-01</in-capmkt:DateOfStartOfReportingPeriod><in-capmkt:DateOfEndOfReportingPeriod contextRef="OneD">2026-09-30</in-capmkt:DateOfEndOfReportingPeriod><in-capmkt:WhetherResultsAreAuditedOrUnaudited contextRef="OneD">Unaudited</in-capmkt:WhetherResultsAreAuditedOrUnaudited><in-capmkt:NatureOfReportStandaloneConsolidated contextRef="OneD">Standalone</in-capmkt:NatureOfReportStandaloneConsolidated><in-capmkt:RevenueFromOperations contextRef="OneD" decimals="-3" unitRef="INR">16687000</in-capmkt:RevenueFromOperations><in-capmkt:OtherIncome contextRef="OneD" decimals="-3" unitRef="INR">1305000</in-capmkt:OtherIncome><in-capmkt:Income contextRef="OneD" decimals="-3" unitRef="INR">17992000</in-capmkt:Income><in-capmkt:CostOfMaterialsConsumed contextRef="OneD" decimals="-3" unitRef="INR">12855000</in-capmkt:CostOfMaterialsConsumed><in-capmkt:PurchasesOfStockInTrade contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:PurchasesOfStockInTrade><in-capmkt:ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade contextRef="OneD" decimals="-3" unitRef="INR">-617000</in-capmkt:ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade><in-capmkt:EmployeeBenefitExpense contextRef="OneD" decimals="-3" unitRef="INR">1873000</in-capmkt:EmployeeBenefitExpense><in-capmkt:FinanceCosts contextRef="OneD" decimals="-3" unitRef="INR">105000</in-capmkt:FinanceCosts><in-capmkt:DepreciationDepletionAndAmortisationExpense contextRef="OneD" decimals="-3" unitRef="INR">684000</in-capmkt:DepreciationDepletionAndAmortisationExpense><in-capmkt:OtherExpenses contextRef="OneD" decimals="-3" unitRef="INR">1551000</in-capmkt:OtherExpenses><in-capmkt:Expenses contextRef="OneD" decimals="-3" unitRef="INR">16451000</in-capmkt:Expenses><in-capmkt:ProfitBeforeExceptionalItemsAndTax contextRef="OneD" decimals="-3" unitRef="INR">1541000</in-capmkt:ProfitBeforeExceptionalItemsAndTax><in-capmkt:ExceptionalItemsBeforeTax contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ExceptionalItemsBeforeTax><in-capmkt:ProfitBeforeTax contextRef="OneD" decimals="-3" unitRef="INR">1541000</in-capmkt:ProfitBeforeTax><in-capmkt:CurrentTax contextRef="OneD" decimals="-3" unitRef="INR">388000</in-capmkt:CurrentTax><in-capmkt:DeferredTax contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:DeferredTax><in-capmkt:TaxExpense contextRef="OneD" decimals="-3" unitRef="INR">388000</in-capmkt:TaxExpense><in-capmkt:NetMovementInRegulatoryDeferralAccountBalancesRelatedToProfitOrLossAndTheRelatedDeferredTaxMovement contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:NetMovementInRegulatoryDeferralAccountBalancesRelatedToProfitOrLossAndTheRelatedDeferredTaxMovement><in-capmkt:ProfitLossForPeriodFromContinuingOperations contextRef="OneD" decimals="-3" unitRef="INR">1153000</in-capmkt:ProfitLossForPeriodFromContinuingOperations><in-capmkt:ProfitLossFromDiscontinuedOperationsBeforeTax contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ProfitLossFromDiscontinuedOperationsBeforeTax><in-capmkt:TaxExpenseOfDiscontinuedOperations contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:TaxExpenseOfDiscontinuedOperations><in-capmkt:ProfitLossFromDiscontinuedOperationsAfterTax contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ProfitLossFromDiscontinuedOperationsAfterTax><in-capmkt:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod><in-capmkt:ProfitLossForPeriod contextRef="OneD" decimals="-3" unitRef="INR">1153000</in-capmkt:ProfitLossForPeriod><in-capmkt:OtherComprehensiveIncomeNetOfTaxes contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:OtherComprehensiveIncomeNetOfTaxes><in-capmkt:ComprehensiveIncomeForThePeriod contextRef="OneD" decimals="-3" unitRef="INR">1153000</in-capmkt:ComprehensiveIncomeForThePeriod><in-capmkt:PaidUpValueOfEquityShareCapital contextRef="OneD" decimals="-3" unitRef="INR">162738000</in-capmkt:PaidUpValueOfEquityShareCapital><in-capmkt:FaceValueOfEquityShareCapital contextRef="OneD" decimals="INF" unitRef="INRPerShare">10</in-capmkt:FaceValueOfEquityShareCapital><in-capmkt:BasicEarningsLossPerShareFromContinuingOperations contextRef="OneD" decimals="INF" unitRef="INRPerShare">0.07</in-capmkt:BasicEarningsLossPerShareFromContinuingOperations><in-capmkt:DilutedEarningsLossPerShareFromContinuingOperations contextRef="OneD" decimals="INF" unitRef="INRPerShare">0.07</in-capmkt:DilutedEarningsLossPerShareFromContinuingOperations><in-capmkt:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="OneD" decimals="INF" unitRef="INRPerShare">0</in-capmkt:BasicEarningsLossPerShareFromDiscontinuedOperations><in-capmkt:DilutedEarningsLossPerShareFromDiscontinuedOperations contextRef="OneD" decimals="INF" unitRef="INRPerShare">0</in-capmkt:DilutedEarningsLossPerShareFromDiscontinuedOperations><in-capmkt:BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations contextRef="OneD" decimals="INF" unitRef="INRPerShare">0.07</in-capmkt:BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations><in-capmkt:DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations contextRef="OneD" decimals="INF" unitRef="INRPerShare">0.07</in-capmkt:DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations><in-capmkt:DisclosureOfNotesOnFinancialResultsExplanatoryTextBlock contextRef="OneD">1.The above Unaudited financial results of "the company" for the 2nd quarter and half year ended 30th September 2026 have been reviewed by the Audit committee and subsequently approved by the Board of Directors in their meeting held on Saturday, 14th Day of November 2026. The above results for the 2nd quarter and half year ended 30th September, 2026 have been reviewed by the statutory auditors of the company in terms of Regulation 33 of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 who have expressed an unmodified opinion. The company’s management has exercised necessary due diligence to ensure that the unaudited financial result provide a true and fair view of its affairs. &lt;br /&gt; 
 &lt;br /&gt; 
2. The Statement of Assets &amp; Liabilities as at September 30, 2026 is annexed with the financial results along with the Cash Flow Statements. &lt;br /&gt; 
 &lt;br /&gt; 
3. This above unaudited Financial Results have been prepared in accordance with the guidelines issued by the Securities and Exchange Board of India (SEBI) and the Companies (Indian Accounting Standards) Rules, 2015 (Ind-AS) prescribed under section 133 of the Companies Act, 2013 and other recognised accounting practices and policies to the extent applicable. &lt;br /&gt; 
 &lt;br /&gt; 
4. The Company has reported segment wise information as per Indian Accounting Standard (Ind AS-108). The Operations of the Company are conducted within India, there is no separate reportable geographical segment and the company reported the following business segments  &lt;br /&gt; 
a. Pharma Product &lt;br /&gt; 
b. Chemicals Division  &lt;br /&gt; 
 &lt;br /&gt; 
5. The figures of the previous period / year have been re-stated/ re-grouped / re-arranged/ reclassified and / or recasted wherever found necessary. &lt;br /&gt; 
 &lt;br /&gt; 
6. The listed entity does not have any subsidiary/associate/joint venture entity(ies) for the respective period. &lt;br /&gt; 
 &lt;br /&gt; 
7.  The aforesaid un-Audited financial Results will be uploaded on the Company’s website www.biofilgroup.net and will also be available  on the websites of the Stock exchanges i.e. www.bseindia.com and www.nseindia.com for the benefit of shareholders and investors.  Further, publication containing a Quick Response code and the details of the webpage where complete financial results of the Company are available, will be published in English and Hindi Newspapers with in prescribed time limit. &lt;br /&gt; 
 &lt;br /&gt; 
8. The Company is presently undertaking renovation and upgradation of its manufacturing facility pursuant to the revision in Schedule M of the Drugs and Cosmetics Rules. The said upgradation work is expected to be completed within approximately 3 to 6 months. The Company expects that, upon completion of the upgradation and commencement of regular manufacturing operations, the enhanced manufacturing capabilities will contribute to an improvement in sales in the subsequent periods. &lt;br /&gt; 
 &lt;br /&gt; 
 &lt;br /&gt; 
</in-capmkt:DisclosureOfNotesOnFinancialResultsExplanatoryTextBlock><in-capmkt:DateOfStartOfReportingPeriod contextRef="FourD">2026-04-01</in-capmkt:DateOfStartOfReportingPeriod><in-capmkt:DateOfEndOfReportingPeriod contextRef="FourD">2026-09-30</in-capmkt:DateOfEndOfReportingPeriod><in-capmkt:WhetherResultsAreAuditedOrUnaudited contextRef="FourD">Unaudited</in-capmkt:WhetherResultsAreAuditedOrUnaudited><in-capmkt:NatureOfReportStandaloneConsolidated contextRef="FourD">Standalone</in-capmkt:NatureOfReportStandaloneConsolidated><in-capmkt:RevenueFromOperations contextRef="FourD" decimals="-3" unitRef="INR">140189000</in-capmkt:RevenueFromOperations><in-capmkt:OtherIncome contextRef="FourD" decimals="-3" unitRef="INR">1931000</in-capmkt:OtherIncome><in-capmkt:Income contextRef="FourD" decimals="-4" unitRef="INR">142120000</in-capmkt:Income><in-capmkt:CostOfMaterialsConsumed contextRef="FourD" decimals="-3" unitRef="INR">107672000</in-capmkt:CostOfMaterialsConsumed><in-capmkt:PurchasesOfStockInTrade contextRef="FourD" decimals="-3" unitRef="INR">31158000</in-capmkt:PurchasesOfStockInTrade><in-capmkt:ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade contextRef="FourD" decimals="-3" unitRef="INR">-8735000</in-capmkt:ChangesInInventoriesOfFinishedGoodsWorkInProgressAndStockInTrade><in-capmkt:EmployeeBenefitExpense contextRef="FourD" decimals="-3" unitRef="INR">3808000</in-capmkt:EmployeeBenefitExpense><in-capmkt:FinanceCosts contextRef="FourD" decimals="-3" unitRef="INR">112000</in-capmkt:FinanceCosts><in-capmkt:DepreciationDepletionAndAmortisationExpense contextRef="FourD" decimals="-3" unitRef="INR">1368000</in-capmkt:DepreciationDepletionAndAmortisationExpense><in-capmkt:OtherExpenses contextRef="FourD" decimals="-3" unitRef="INR">3855000</in-capmkt:OtherExpenses><in-capmkt:Expenses contextRef="FourD" decimals="-3" unitRef="INR">139238000</in-capmkt:Expenses><in-capmkt:ProfitBeforeExceptionalItemsAndTax contextRef="FourD" decimals="-3" unitRef="INR">2882000</in-capmkt:ProfitBeforeExceptionalItemsAndTax><in-capmkt:ExceptionalItemsBeforeTax contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ExceptionalItemsBeforeTax><in-capmkt:ProfitBeforeTax contextRef="FourD" decimals="-3" unitRef="INR">2882000</in-capmkt:ProfitBeforeTax><in-capmkt:CurrentTax contextRef="FourD" decimals="-3" unitRef="INR">638000</in-capmkt:CurrentTax><in-capmkt:DeferredTax contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:DeferredTax><in-capmkt:TaxExpense contextRef="FourD" decimals="-3" unitRef="INR">638000</in-capmkt:TaxExpense><in-capmkt:NetMovementInRegulatoryDeferralAccountBalancesRelatedToProfitOrLossAndTheRelatedDeferredTaxMovement contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:NetMovementInRegulatoryDeferralAccountBalancesRelatedToProfitOrLossAndTheRelatedDeferredTaxMovement><in-capmkt:ProfitLossForPeriodFromContinuingOperations contextRef="FourD" decimals="-3" unitRef="INR">2244000</in-capmkt:ProfitLossForPeriodFromContinuingOperations><in-capmkt:ProfitLossFromDiscontinuedOperationsBeforeTax contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProfitLossFromDiscontinuedOperationsBeforeTax><in-capmkt:TaxExpenseOfDiscontinuedOperations contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:TaxExpenseOfDiscontinuedOperations><in-capmkt:ProfitLossFromDiscontinuedOperationsAfterTax contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProfitLossFromDiscontinuedOperationsAfterTax><in-capmkt:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod><in-capmkt:ProfitLossForPeriod contextRef="FourD" decimals="-3" unitRef="INR">2244000</in-capmkt:ProfitLossForPeriod><in-capmkt:OtherComprehensiveIncomeNetOfTaxes contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:OtherComprehensiveIncomeNetOfTaxes><in-capmkt:ComprehensiveIncomeForThePeriod contextRef="FourD" decimals="-3" unitRef="INR">2244000</in-capmkt:ComprehensiveIncomeForThePeriod><in-capmkt:PaidUpValueOfEquityShareCapital contextRef="FourD" decimals="-3" unitRef="INR">162738000</in-capmkt:PaidUpValueOfEquityShareCapital><in-capmkt:FaceValueOfEquityShareCapital contextRef="FourD" decimals="INF" unitRef="INRPerShare">10</in-capmkt:FaceValueOfEquityShareCapital><in-capmkt:BasicEarningsLossPerShareFromContinuingOperations contextRef="FourD" decimals="INF" unitRef="INRPerShare">0.14</in-capmkt:BasicEarningsLossPerShareFromContinuingOperations><in-capmkt:DilutedEarningsLossPerShareFromContinuingOperations contextRef="FourD" decimals="INF" unitRef="INRPerShare">0.14</in-capmkt:DilutedEarningsLossPerShareFromContinuingOperations><in-capmkt:BasicEarningsLossPerShareFromDiscontinuedOperations contextRef="FourD" decimals="INF" unitRef="INRPerShare">0</in-capmkt:BasicEarningsLossPerShareFromDiscontinuedOperations><in-capmkt:DilutedEarningsLossPerShareFromDiscontinuedOperations contextRef="FourD" decimals="INF" unitRef="INRPerShare">0</in-capmkt:DilutedEarningsLossPerShareFromDiscontinuedOperations><in-capmkt:BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations contextRef="FourD" decimals="INF" unitRef="INRPerShare">0.14</in-capmkt:BasicEarningsLossPerShareFromContinuingAndDiscontinuedOperations><in-capmkt:DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations contextRef="FourD" decimals="INF" unitRef="INRPerShare">0.14</in-capmkt:DilutedEarningsLossPerShareFromContinuingAndDiscontinuedOperations><in-capmkt:DescriptionOfOtherExpenses contextRef="OneExpenses1D">Manufacturing Expenses</in-capmkt:DescriptionOfOtherExpenses><in-capmkt:OtherExpenses contextRef="OneExpenses1D" decimals="-3" unitRef="INR">746000</in-capmkt:OtherExpenses><in-capmkt:DescriptionOfOtherExpenses contextRef="OneExpenses2D">Administrative Expenses</in-capmkt:DescriptionOfOtherExpenses><in-capmkt:OtherExpenses contextRef="OneExpenses2D" decimals="-4" unitRef="INR">690000</in-capmkt:OtherExpenses><in-capmkt:DescriptionOfOtherExpenses contextRef="OneExpenses3D">Selling and Distribution Expenses</in-capmkt:DescriptionOfOtherExpenses><in-capmkt:OtherExpenses contextRef="OneExpenses3D" decimals="-3" unitRef="INR">115000</in-capmkt:OtherExpenses><in-capmkt:DescriptionOfOtherExpenses contextRef="FourExpenses1D">Manufacturing Expenses</in-capmkt:DescriptionOfOtherExpenses><in-capmkt:OtherExpenses contextRef="FourExpenses1D" decimals="-4" unitRef="INR">1340000</in-capmkt:OtherExpenses><in-capmkt:DescriptionOfOtherExpenses contextRef="FourExpenses2D">Administrative Expenses</in-capmkt:DescriptionOfOtherExpenses><in-capmkt:OtherExpenses contextRef="FourExpenses2D" decimals="-3" unitRef="INR">2319000</in-capmkt:OtherExpenses><in-capmkt:DescriptionOfOtherExpenses contextRef="FourExpenses3D">Selling and Distribution Expenses</in-capmkt:DescriptionOfOtherExpenses><in-capmkt:OtherExpenses contextRef="FourExpenses3D" decimals="-3" unitRef="INR">196000</in-capmkt:OtherExpenses><in-capmkt:PropertyPlantAndEquipment contextRef="OneI" decimals="-3" unitRef="INR">68901000</in-capmkt:PropertyPlantAndEquipment><in-capmkt:Goodwill contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:Goodwill><in-capmkt:OtherIntangibleAssets contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:OtherIntangibleAssets><in-capmkt:NoncurrentInvestments contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:NoncurrentInvestments><in-capmkt:LoansNoncurrent contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:LoansNoncurrent><in-capmkt:NoncurrentFinancialAssets contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:NoncurrentFinancialAssets><in-capmkt:DeferredTaxAssetsNet contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:DeferredTaxAssetsNet><in-capmkt:OtherNoncurrentAssets contextRef="OneI" decimals="-3" unitRef="INR">503000</in-capmkt:OtherNoncurrentAssets><in-capmkt:NoncurrentAssets contextRef="OneI" decimals="-3" unitRef="INR">69404000</in-capmkt:NoncurrentAssets><in-capmkt:Inventories contextRef="OneI" decimals="-3" unitRef="INR">48731000</in-capmkt:Inventories><in-capmkt:CurrentInvestments contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:CurrentInvestments><in-capmkt:TradeReceivablesCurrent contextRef="OneI" decimals="-3" unitRef="INR">384788000</in-capmkt:TradeReceivablesCurrent><in-capmkt:CashAndCashEquivalents contextRef="OneI" decimals="-3" unitRef="INR">433000</in-capmkt:CashAndCashEquivalents><in-capmkt:BankBalanceOtherThanCashAndCashEquivalents contextRef="OneI" decimals="-3" unitRef="INR">19758000</in-capmkt:BankBalanceOtherThanCashAndCashEquivalents><in-capmkt:LoansCurrent contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:LoansCurrent><in-capmkt:CurrentFinancialAssets contextRef="OneI" decimals="-3" unitRef="INR">404979000</in-capmkt:CurrentFinancialAssets><in-capmkt:OtherCurrentAssets contextRef="OneI" decimals="-3" unitRef="INR">10044000</in-capmkt:OtherCurrentAssets><in-capmkt:CurrentAssets contextRef="OneI" decimals="-3" unitRef="INR">463754000</in-capmkt:CurrentAssets><in-capmkt:Assets contextRef="OneI" decimals="-3" unitRef="INR">533158000</in-capmkt:Assets><in-capmkt:EquityShareCapital contextRef="OneI" decimals="-3" unitRef="INR">162738000</in-capmkt:EquityShareCapital><in-capmkt:OtherEquity contextRef="OneI" decimals="-3" unitRef="INR">55149000</in-capmkt:OtherEquity><in-capmkt:EquityAttributableToOwnersOfParent contextRef="OneI" decimals="-3" unitRef="INR">217887000</in-capmkt:EquityAttributableToOwnersOfParent><in-capmkt:Equity contextRef="OneI" decimals="-3" unitRef="INR">217887000</in-capmkt:Equity><in-capmkt:BorrowingsNoncurrent contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:BorrowingsNoncurrent><in-capmkt:NoncurrentFinancialLiabilities contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:NoncurrentFinancialLiabilities><in-capmkt:ProvisionsNoncurrent contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:ProvisionsNoncurrent><in-capmkt:DeferredTaxLiabilitiesNet contextRef="OneI" decimals="-3" unitRef="INR">5945000</in-capmkt:DeferredTaxLiabilitiesNet><in-capmkt:NoncurrentLiabilities contextRef="OneI" decimals="-3" unitRef="INR">5945000</in-capmkt:NoncurrentLiabilities><in-capmkt:BorrowingsCurrent contextRef="OneI" decimals="-5" unitRef="INR">21700000</in-capmkt:BorrowingsCurrent><in-capmkt:TotalOutstandingDuesOfMicroEnterpriseAndSmallEnterpriseCurrent contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:TotalOutstandingDuesOfMicroEnterpriseAndSmallEnterpriseCurrent><in-capmkt:TotalOutstandingDuesOfCreditorsOtherThanMicroEnterpriseAndSmallEnterpriseCurrent contextRef="OneI" decimals="-3" unitRef="INR">286718000</in-capmkt:TotalOutstandingDuesOfCreditorsOtherThanMicroEnterpriseAndSmallEnterpriseCurrent><in-capmkt:TradePayablesCurrent contextRef="OneI" decimals="-3" unitRef="INR">286718000</in-capmkt:TradePayablesCurrent><in-capmkt:CurrentFinancialLiabilities contextRef="OneI" decimals="-3" unitRef="INR">308418000</in-capmkt:CurrentFinancialLiabilities><in-capmkt:OtherCurrentLiabilities contextRef="OneI" decimals="-3" unitRef="INR">267000</in-capmkt:OtherCurrentLiabilities><in-capmkt:ProvisionsCurrent contextRef="OneI" decimals="-3" unitRef="INR">641000</in-capmkt:ProvisionsCurrent><in-capmkt:CurrentLiabilities contextRef="OneI" decimals="-3" unitRef="INR">309326000</in-capmkt:CurrentLiabilities><in-capmkt:Liabilities contextRef="OneI" decimals="-3" unitRef="INR">315271000</in-capmkt:Liabilities><in-capmkt:EquityAndLiabilities contextRef="OneI" decimals="-3" unitRef="INR">533158000</in-capmkt:EquityAndLiabilities><in-capmkt:DescriptionOfOtherNoncurrentAssets contextRef="I_OtherNoncurrentAssets1">Security Deposit</in-capmkt:DescriptionOfOtherNoncurrentAssets><in-capmkt:OtherNoncurrentAssets contextRef="I_OtherNoncurrentAssets1" decimals="-3" unitRef="INR">503000</in-capmkt:OtherNoncurrentAssets><in-capmkt:DescriptionOfOtherCurrentAssets contextRef="I_OtherCurrentAssets1">Advance against material</in-capmkt:DescriptionOfOtherCurrentAssets><in-capmkt:OtherCurrentAssets contextRef="I_OtherCurrentAssets1" decimals="-3" unitRef="INR">3048000</in-capmkt:OtherCurrentAssets><in-capmkt:DescriptionOfOtherCurrentAssets contextRef="I_OtherCurrentAssets2">Balance with Government Authorities</in-capmkt:DescriptionOfOtherCurrentAssets><in-capmkt:OtherCurrentAssets contextRef="I_OtherCurrentAssets2" decimals="-3" unitRef="INR">4932000</in-capmkt:OtherCurrentAssets><in-capmkt:DescriptionOfOtherCurrentAssets contextRef="I_OtherCurrentAssets3">Other assets</in-capmkt:DescriptionOfOtherCurrentAssets><in-capmkt:OtherCurrentAssets contextRef="I_OtherCurrentAssets3" decimals="-3" unitRef="INR">2064000</in-capmkt:OtherCurrentAssets><in-capmkt:DescriptionOfOtherCurrentLiabilities contextRef="I_OtherCurrentLiabilities1">Employee Benefits Payble</in-capmkt:DescriptionOfOtherCurrentLiabilities><in-capmkt:OtherCurrentLiabilities contextRef="I_OtherCurrentLiabilities1" decimals="-3" unitRef="INR">211000</in-capmkt:OtherCurrentLiabilities><in-capmkt:DescriptionOfOtherCurrentLiabilities contextRef="I_OtherCurrentLiabilities2">Other Payable</in-capmkt:DescriptionOfOtherCurrentLiabilities><in-capmkt:OtherCurrentLiabilities contextRef="I_OtherCurrentLiabilities2" decimals="-3" unitRef="INR">56000</in-capmkt:OtherCurrentLiabilities><in-capmkt:DescriptionOfReportableSegment contextRef="OneReportable1D">Pharma Unit</in-capmkt:DescriptionOfReportableSegment><in-capmkt:SegmentRevenue contextRef="OneReportable1D" decimals="-3" unitRef="INR">16687000</in-capmkt:SegmentRevenue><in-capmkt:DescriptionOfReportableSegment contextRef="OneReportable2D">Chemicals Division</in-capmkt:DescriptionOfReportableSegment><in-capmkt:SegmentRevenue contextRef="OneReportable2D" decimals="-5" unitRef="INR">0</in-capmkt:SegmentRevenue><in-capmkt:DescriptionOfReportableSegment contextRef="FourReportable1D">Pharma Unit</in-capmkt:DescriptionOfReportableSegment><in-capmkt:SegmentRevenue contextRef="FourReportable1D" decimals="-3" unitRef="INR">48027000</in-capmkt:SegmentRevenue><in-capmkt:DescriptionOfReportableSegment contextRef="FourReportable2D">Chemicals Division</in-capmkt:DescriptionOfReportableSegment><in-capmkt:SegmentRevenue contextRef="FourReportable2D" decimals="-3" unitRef="INR">92162000</in-capmkt:SegmentRevenue><in-capmkt:SegmentRevenue contextRef="OneD" decimals="-3" unitRef="INR">16687000</in-capmkt:SegmentRevenue><in-capmkt:SegmentRevenue contextRef="FourD" decimals="-3" unitRef="INR">140189000</in-capmkt:SegmentRevenue><in-capmkt:SegmentRevenueFromOperations contextRef="OneD" decimals="-3" unitRef="INR">16687000</in-capmkt:SegmentRevenueFromOperations><in-capmkt:SegmentRevenueFromOperations contextRef="FourD" decimals="-3" unitRef="INR">140189000</in-capmkt:SegmentRevenueFromOperations><in-capmkt:DescriptionOfReportableSegment contextRef="OneReportableFinance1D">Pharma Unit</in-capmkt:DescriptionOfReportableSegment><in-capmkt:SegmentProfitLossBeforeTaxAndFinanceCosts contextRef="OneReportableFinance1D" decimals="-3" unitRef="INR">126000</in-capmkt:SegmentProfitLossBeforeTaxAndFinanceCosts><in-capmkt:DescriptionOfReportableSegment contextRef="OneReportableFinance2D">Chemicals Division</in-capmkt:DescriptionOfReportableSegment><in-capmkt:SegmentProfitLossBeforeTaxAndFinanceCosts contextRef="OneReportableFinance2D" decimals="-3" unitRef="INR">1023000</in-capmkt:SegmentProfitLossBeforeTaxAndFinanceCosts><in-capmkt:DescriptionOfReportableSegment contextRef="FourReportableFinance1D">Pharma Unit</in-capmkt:DescriptionOfReportableSegment><in-capmkt:SegmentProfitLossBeforeTaxAndFinanceCosts contextRef="FourReportableFinance1D" decimals="-3" unitRef="INR">-515000</in-capmkt:SegmentProfitLossBeforeTaxAndFinanceCosts><in-capmkt:DescriptionOfReportableSegment contextRef="FourReportableFinance2D">Chemicals Division</in-capmkt:DescriptionOfReportableSegment><in-capmkt:SegmentProfitLossBeforeTaxAndFinanceCosts contextRef="FourReportableFinance2D" decimals="-3" unitRef="INR">2566000</in-capmkt:SegmentProfitLossBeforeTaxAndFinanceCosts><in-capmkt:SegmentProfitLossBeforeTaxAndFinanceCosts contextRef="OneD" decimals="-3" unitRef="INR">1149000</in-capmkt:SegmentProfitLossBeforeTaxAndFinanceCosts><in-capmkt:SegmentProfitLossBeforeTaxAndFinanceCosts contextRef="FourD" decimals="-3" unitRef="INR">2051000</in-capmkt:SegmentProfitLossBeforeTaxAndFinanceCosts><in-capmkt:SegmentFinanceCosts contextRef="OneD" decimals="-3" unitRef="INR">-392000</in-capmkt:SegmentFinanceCosts><in-capmkt:SegmentFinanceCosts contextRef="FourD" decimals="-3" unitRef="INR">-831000</in-capmkt:SegmentFinanceCosts><in-capmkt:OtherUnallocableExpenditureNetOffUnAllocableIncome contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:OtherUnallocableExpenditureNetOffUnAllocableIncome><in-capmkt:OtherUnallocableExpenditureNetOffUnAllocableIncome contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:OtherUnallocableExpenditureNetOffUnAllocableIncome><in-capmkt:SegmentProfitBeforeTax contextRef="OneD" decimals="-3" unitRef="INR">1541000</in-capmkt:SegmentProfitBeforeTax><in-capmkt:SegmentProfitBeforeTax contextRef="FourD" decimals="-3" unitRef="INR">2882000</in-capmkt:SegmentProfitBeforeTax><in-capmkt:DescriptionOfReportableSegment contextRef="OneReportable31D">Pharma Unit</in-capmkt:DescriptionOfReportableSegment><in-capmkt:SegmentAssets contextRef="OneReportable31I" decimals="-3" unitRef="INR">243874000</in-capmkt:SegmentAssets><in-capmkt:DescriptionOfReportableSegment contextRef="OneReportable32D">Chemicals Division</in-capmkt:DescriptionOfReportableSegment><in-capmkt:SegmentAssets contextRef="OneReportable32I" decimals="-3" unitRef="INR">289284000</in-capmkt:SegmentAssets><in-capmkt:SegmentAssets contextRef="OneI" decimals="-3" unitRef="INR">533158000</in-capmkt:SegmentAssets><in-capmkt:UnAllocableAssets contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:UnAllocableAssets><in-capmkt:NetSegmentAssets contextRef="OneI" decimals="-3" unitRef="INR">533158000</in-capmkt:NetSegmentAssets><in-capmkt:DescriptionOfReportableSegment contextRef="OneReportable41D">Pharma Unit</in-capmkt:DescriptionOfReportableSegment><in-capmkt:SegmentLiabilities contextRef="OneReportable41I" decimals="-3" unitRef="INR">162103000</in-capmkt:SegmentLiabilities><in-capmkt:DescriptionOfReportableSegment contextRef="OneReportable42D">Chemicals Division</in-capmkt:DescriptionOfReportableSegment><in-capmkt:SegmentLiabilities contextRef="OneReportable42I" decimals="-3" unitRef="INR">153168000</in-capmkt:SegmentLiabilities><in-capmkt:SegmentLiabilities contextRef="OneI" decimals="-3" unitRef="INR">315271000</in-capmkt:SegmentLiabilities><in-capmkt:UnAllocableLiabilities contextRef="OneI" decimals="-5" unitRef="INR">0</in-capmkt:UnAllocableLiabilities><in-capmkt:NetSegmentLiabilities contextRef="OneI" decimals="-3" unitRef="INR">315271000</in-capmkt:NetSegmentLiabilities><in-capmkt:AdjustmentsForFinanceCosts contextRef="FourD" decimals="-3" unitRef="INR">112000</in-capmkt:AdjustmentsForFinanceCosts><in-capmkt:AdjustmentsForDecreaseIncreaseInInventories contextRef="FourD" decimals="-3" unitRef="INR">-8734000</in-capmkt:AdjustmentsForDecreaseIncreaseInInventories><in-capmkt:AdjustmentsForDecreaseIncreaseInTradeReceivablesCurrent contextRef="FourD" decimals="-3" unitRef="INR">-108928000</in-capmkt:AdjustmentsForDecreaseIncreaseInTradeReceivablesCurrent><in-capmkt:AdjustmentsForDecreaseIncreaseInTradeReceivablesNoncurrent contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForDecreaseIncreaseInTradeReceivablesNoncurrent><in-capmkt:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets contextRef="FourD" decimals="-3" unitRef="INR">-538000</in-capmkt:AdjustmentsForDecreaseIncreaseInOtherCurrentAssets><in-capmkt:AdjustmentsForDecreaseIncreaseInOtherNoncurrentAssets contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForDecreaseIncreaseInOtherNoncurrentAssets><in-capmkt:AdjustmentsForOtherFinancialAssetsNoncurrent contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForOtherFinancialAssetsNoncurrent><in-capmkt:AdjustmentsForOtherFinancialAssetsCurrent contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForOtherFinancialAssetsCurrent><in-capmkt:AdjustmentsForOtherBankBalances contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForOtherBankBalances><in-capmkt:AdjustmentsForIncreaseDecreaseInTradePayablesCurrent contextRef="FourD" decimals="-3" unitRef="INR">116114000</in-capmkt:AdjustmentsForIncreaseDecreaseInTradePayablesCurrent><in-capmkt:AdjustmentsForIncreaseDecreaseInTradePayablesNoncurrent contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForIncreaseDecreaseInTradePayablesNoncurrent><in-capmkt:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities contextRef="FourD" decimals="-4" unitRef="INR">-1750000</in-capmkt:AdjustmentsForIncreaseDecreaseInOtherCurrentLiabilities><in-capmkt:AdjustmentsForIncreaseDecreaseInOtherNoncurrentLiabilities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForIncreaseDecreaseInOtherNoncurrentLiabilities><in-capmkt:AdjustmentsForDepreciationAndAmortisationExpense contextRef="FourD" decimals="-3" unitRef="INR">1368000</in-capmkt:AdjustmentsForDepreciationAndAmortisationExpense><in-capmkt:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss><in-capmkt:AdjustmentsForProvisionsCurrent contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForProvisionsCurrent><in-capmkt:AdjustmentsForProvisionsNoncurrent contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForProvisionsNoncurrent><in-capmkt:AdjustmentsForOtherFinancialLiabilitiesCurrent contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForOtherFinancialLiabilitiesCurrent><in-capmkt:AdjustmentsForOtherFinancialLiabilitiesNoncurrent contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForOtherFinancialLiabilitiesNoncurrent><in-capmkt:AdjustmentsForUnrealisedForeignExchangeLossesGains contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForUnrealisedForeignExchangeLossesGains><in-capmkt:AdjustmentsForDividendIncome contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForDividendIncome><in-capmkt:AdjustmentsForInterestIncome contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForInterestIncome><in-capmkt:AdjustmentsForSharebasedPayments contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForSharebasedPayments><in-capmkt:AdjustmentsForFairValueGainsLosses contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForFairValueGainsLosses><in-capmkt:AdjustmentsForUndistributedProfitsOfAssociates contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:AdjustmentsForUndistributedProfitsOfAssociates><in-capmkt:OtherAdjustmentsForWhichCashEffectsAreInvestingOrFinancingCashFlow contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:OtherAdjustmentsForWhichCashEffectsAreInvestingOrFinancingCashFlow><in-capmkt:OtherAdjustmentsToReconcileProfitLoss contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:OtherAdjustmentsToReconcileProfitLoss><in-capmkt:OtherAdjustmentsForNoncashItems contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:OtherAdjustmentsForNoncashItems><in-capmkt:ShareOfProfitAndLossFromPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ShareOfProfitAndLossFromPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships><in-capmkt:AdjustmentsForReconcileProfitLoss contextRef="FourD" decimals="-3" unitRef="INR">-2356000</in-capmkt:AdjustmentsForReconcileProfitLoss><in-capmkt:CashFlowsFromUsedInOperations contextRef="FourD" decimals="-3" unitRef="INR">526000</in-capmkt:CashFlowsFromUsedInOperations><in-capmkt:DividendsReceivedClassifiedAsOperatingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:DividendsReceivedClassifiedAsOperatingActivities><in-capmkt:InterestPaidClassifiedAsOperatingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:InterestPaidClassifiedAsOperatingActivities><in-capmkt:InterestReceivedClassifiedAsOperatingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:InterestReceivedClassifiedAsOperatingActivities><in-capmkt:IncomeTaxesPaidRefundClassifiedAsOperatingActivities contextRef="FourD" decimals="-3" unitRef="INR">4558000</in-capmkt:IncomeTaxesPaidRefundClassifiedAsOperatingActivities><in-capmkt:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:OtherInflowsOutflowsOfCashClassifiedAsOperatingActivities><in-capmkt:CashFlowsFromUsedInOperatingActivities contextRef="FourD" decimals="-3" unitRef="INR">-4032000</in-capmkt:CashFlowsFromUsedInOperatingActivities><in-capmkt:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities><in-capmkt:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities><in-capmkt:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:OtherCashReceiptsFromSalesOfEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities><in-capmkt:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:OtherCashPaymentsToAcquireEquityOrDebtInstrumentsOfOtherEntitiesClassifiedAsInvestingActivities><in-capmkt:OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:OtherCashReceiptsFromSalesOfInterestsInJointVenturesClassifiedAsInvestingActivities><in-capmkt:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:OtherCashPaymentsToAcquireInterestsInJointVenturesClassifiedAsInvestingActivities><in-capmkt:CashReceiptsFromShareOfProfitsOfPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:CashReceiptsFromShareOfProfitsOfPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships><in-capmkt:CashPaymentForInvestmentInPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:CashPaymentForInvestmentInPartnershipFirmOrAssociationOfPersonsOrLimitedLiabilityPartnerships><in-capmkt:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities><in-capmkt:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities contextRef="FourD" decimals="-4" unitRef="INR">920000</in-capmkt:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities><in-capmkt:ProceedsFromSalesOfInvestmentPropertyClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromSalesOfInvestmentPropertyClassifiedAsInvestingActivities><in-capmkt:PurchaseOfInvestmentPropertyClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:PurchaseOfInvestmentPropertyClassifiedAsInvestingActivities><in-capmkt:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromSalesOfIntangibleAssetsClassifiedAsInvestingActivities><in-capmkt:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities><in-capmkt:ProceedsFromSalesOfIntangibleAssetsUnderDevelopment contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromSalesOfIntangibleAssetsUnderDevelopment><in-capmkt:PurchaseOfIntangibleAssetsUnderDevelopment contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:PurchaseOfIntangibleAssetsUnderDevelopment><in-capmkt:ProceedsFromSalesOfGoodwillClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromSalesOfGoodwillClassifiedAsInvestingActivities><in-capmkt:PurchaseOfGoodwillClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:PurchaseOfGoodwillClassifiedAsInvestingActivities><in-capmkt:ProceedsFromBiologicalAssetsOtherThanBearerPlantsClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromBiologicalAssetsOtherThanBearerPlantsClassifiedAsInvestingActivities><in-capmkt:PurchaseOfBiologicalAssetsOtherThanBearerPlantsClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:PurchaseOfBiologicalAssetsOtherThanBearerPlantsClassifiedAsInvestingActivities><in-capmkt:ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromGovernmentGrantsClassifiedAsInvestingActivities><in-capmkt:ProceedsFromSalesOfOtherLongTermAssetsClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromSalesOfOtherLongTermAssetsClassifiedAsInvestingActivities><in-capmkt:PurchaseOfOtherLongTermAssetsClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:PurchaseOfOtherLongTermAssetsClassifiedAsInvestingActivities><in-capmkt:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:CashAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities><in-capmkt:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:CashReceiptsFromRepaymentOfAdvancesAndLoansMadeToOtherPartiesClassifiedAsInvestingActivities><in-capmkt:CashPaymentsForFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:CashPaymentsForFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities><in-capmkt:CashReceiptsFromFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:CashReceiptsFromFutureContractsForwardContractsOptionContractsAndSwapContractsClassifiedAsInvestingActivities><in-capmkt:DividendsReceivedClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:DividendsReceivedClassifiedAsInvestingActivities><in-capmkt:InterestReceivedClassifiedAsInvestingActivities contextRef="FourD" decimals="-3" unitRef="INR">491000</in-capmkt:InterestReceivedClassifiedAsInvestingActivities><in-capmkt:IncomeTaxesPaidRefundClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:IncomeTaxesPaidRefundClassifiedAsInvestingActivities><in-capmkt:OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:OtherInflowsOutflowsOfCashClassifiedAsInvestingActivities><in-capmkt:CashFlowsFromUsedInInvestingActivities contextRef="FourD" decimals="-3" unitRef="INR">-429000</in-capmkt:CashFlowsFromUsedInInvestingActivities><in-capmkt:ProceedsFromChangesInOwnershipInterestsInSubsidiaries contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromChangesInOwnershipInterestsInSubsidiaries><in-capmkt:PaymentsFromChangesInOwnershipInterestsInSubsidiaries contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:PaymentsFromChangesInOwnershipInterestsInSubsidiaries><in-capmkt:ProceedsFromIssuingSharesClassifiedAsFinancingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromIssuingSharesClassifiedAsFinancingActivities><in-capmkt:ProceedsFromIssuingOtherEquityInstruments contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromIssuingOtherEquityInstruments><in-capmkt:PaymentsToAcquireOrRedeemEntitysShares contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:PaymentsToAcquireOrRedeemEntitysShares><in-capmkt:PaymentsOfOtherEquityInstruments contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:PaymentsOfOtherEquityInstruments><in-capmkt:ProceedsFromExerciseOfStockOptions contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromExerciseOfStockOptions><in-capmkt:ProceedsFromIssuingDebenturesNotesBondsEtc contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromIssuingDebenturesNotesBondsEtc><in-capmkt:ProceedsFromBorrowingsClassifiedAsFinancingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:ProceedsFromBorrowingsClassifiedAsFinancingActivities><in-capmkt:RepaymentsOfBorrowingsClassifiedAsFinancingActivities contextRef="FourD" decimals="-5" unitRef="INR">8500000</in-capmkt:RepaymentsOfBorrowingsClassifiedAsFinancingActivities><in-capmkt:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities><in-capmkt:DividendsPaidClassifiedAsFinancingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:DividendsPaidClassifiedAsFinancingActivities><in-capmkt:InterestPaidClassifiedAsFinancingActivities contextRef="FourD" decimals="-3" unitRef="INR">112000</in-capmkt:InterestPaidClassifiedAsFinancingActivities><in-capmkt:IncomeTaxesPaidRefundClassifiedAsFinancingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:IncomeTaxesPaidRefundClassifiedAsFinancingActivities><in-capmkt:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:OtherInflowsOutflowsOfCashClassifiedAsFinancingActivities><in-capmkt:CashFlowsFromUsedInFinancingActivities contextRef="FourD" decimals="-3" unitRef="INR">-8612000</in-capmkt:CashFlowsFromUsedInFinancingActivities><in-capmkt:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges contextRef="FourD" decimals="-3" unitRef="INR">-13073000</in-capmkt:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges><in-capmkt:EffectOfExchangeRateChangesOnCashAndCashEquivalents contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:EffectOfExchangeRateChangesOnCashAndCashEquivalents><in-capmkt:IncreaseDecreaseInCashAndCashEquivalents contextRef="FourD" decimals="-3" unitRef="INR">-13073000</in-capmkt:IncreaseDecreaseInCashAndCashEquivalents><in-capmkt:CashAndCashEquivalentsCashFlowStatement contextRef="PY_I" decimals="-3" unitRef="INR">33264000</in-capmkt:CashAndCashEquivalentsCashFlowStatement><in-capmkt:CashAndCashEquivalentsCashFlowStatement contextRef="OneI" decimals="-3" unitRef="INR">20191000</in-capmkt:CashAndCashEquivalentsCashFlowStatement><in-capmkt:IncomeTaxRelatingToItemsThatWillNotBeReclassifiedToProfitOrLoss contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:IncomeTaxRelatingToItemsThatWillNotBeReclassifiedToProfitOrLoss><in-capmkt:IncomeTaxRelatingToItemsThatWillNotBeReclassifiedToProfitOrLoss contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:IncomeTaxRelatingToItemsThatWillNotBeReclassifiedToProfitOrLoss><in-capmkt:IncomeTaxRelatingToItemsThatWillBeReclassifiedToProfitOrLoss contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:IncomeTaxRelatingToItemsThatWillBeReclassifiedToProfitOrLoss><in-capmkt:IncomeTaxRelatingToItemsThatWillBeReclassifiedToProfitOrLoss contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:IncomeTaxRelatingToItemsThatWillBeReclassifiedToProfitOrLoss><in-capmkt:OtherComprehensiveIncome contextRef="OneD" decimals="-5" unitRef="INR">0</in-capmkt:OtherComprehensiveIncome><in-capmkt:OtherComprehensiveIncome contextRef="FourD" decimals="-5" unitRef="INR">0</in-capmkt:OtherComprehensiveIncome><in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_RelatedPartyTransaction1">BIOFIL CHEMICALS AND PHARMACEUTICALS LTD.</in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:PANOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_RelatedPartyTransaction1">******</in-capmkt:PANOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:NameOfCounterParty contextRef="D_RelatedPartyTransaction1">CYANO PHARMA PVT LTD</in-capmkt:NameOfCounterParty><in-capmkt:PANOfCounterParty contextRef="D_RelatedPartyTransaction1">******</in-capmkt:PANOfCounterParty><in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary contextRef="D_RelatedPartyTransaction1">Directors and their relatives are Members in the Company	</in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary><in-capmkt:TypeOfRelatedPartyTransaction contextRef="D_RelatedPartyTransaction1">Sale of goods or services</in-capmkt:TypeOfRelatedPartyTransaction><in-capmkt:ValueOfTheRelatedPartyTransactionAsApprovedByTheAuditCommittee contextRef="D_RelatedPartyTransaction1" decimals="-5" unitRef="INR">200000000</in-capmkt:ValueOfTheRelatedPartyTransactionAsApprovedByTheAuditCommittee><in-capmkt:RemarksOnApprovalByAuditCommittee contextRef="D_RelatedPartyTransaction1">Approved by Audit Committee and also from members</in-capmkt:RemarksOnApprovalByAuditCommittee><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="D_RelatedPartyTransaction1" decimals="-3" unitRef="INR">9644000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod><in-capmkt:AmountOfRelatedPartyTransaction contextRef="I_RelatedPartyTransaction_PY1" decimals="-5" unitRef="INR">0</in-capmkt:AmountOfRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransaction contextRef="I_RelatedPartyTransaction1" decimals="-3" unitRef="INR">6352000</in-capmkt:AmountOfRelatedPartyTransaction><in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_RelatedPartyTransaction2">BIOFIL CHEMICALS AND PHARMACEUTICALS LTD.</in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:PANOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_RelatedPartyTransaction2">******</in-capmkt:PANOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:NameOfCounterParty contextRef="D_RelatedPartyTransaction2">CYANO PHARMA PVT LTD</in-capmkt:NameOfCounterParty><in-capmkt:PANOfCounterParty contextRef="D_RelatedPartyTransaction2">******</in-capmkt:PANOfCounterParty><in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary contextRef="D_RelatedPartyTransaction2">Directors and their relatives are Members in the Company	</in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary><in-capmkt:TypeOfRelatedPartyTransaction contextRef="D_RelatedPartyTransaction2">Purchase of goods or services</in-capmkt:TypeOfRelatedPartyTransaction><in-capmkt:ValueOfTheRelatedPartyTransactionAsApprovedByTheAuditCommittee contextRef="D_RelatedPartyTransaction2" decimals="-5" unitRef="INR">200000000</in-capmkt:ValueOfTheRelatedPartyTransactionAsApprovedByTheAuditCommittee><in-capmkt:RemarksOnApprovalByAuditCommittee contextRef="D_RelatedPartyTransaction2">Approved by Audit Committee and also from members</in-capmkt:RemarksOnApprovalByAuditCommittee><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="D_RelatedPartyTransaction2" decimals="-3" unitRef="INR">676000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod><in-capmkt:AmountOfRelatedPartyTransaction contextRef="I_RelatedPartyTransaction_PY2" decimals="-3" unitRef="INR">38662000</in-capmkt:AmountOfRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransaction contextRef="I_RelatedPartyTransaction2" decimals="-3" unitRef="INR">45392000</in-capmkt:AmountOfRelatedPartyTransaction><in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_RelatedPartyTransaction3">BIOFIL CHEMICALS AND PHARMACEUTICALS LTD.</in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:PANOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_RelatedPartyTransaction3">******</in-capmkt:PANOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:NameOfCounterParty contextRef="D_RelatedPartyTransaction3">FORMO PLAST PVT LTD</in-capmkt:NameOfCounterParty><in-capmkt:PANOfCounterParty contextRef="D_RelatedPartyTransaction3">******</in-capmkt:PANOfCounterParty><in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary contextRef="D_RelatedPartyTransaction3">Directors and their relatives are Directors and Members in the Company</in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary><in-capmkt:TypeOfRelatedPartyTransaction contextRef="D_RelatedPartyTransaction3">Purchase of goods or services</in-capmkt:TypeOfRelatedPartyTransaction><in-capmkt:ValueOfTheRelatedPartyTransactionAsApprovedByTheAuditCommittee contextRef="D_RelatedPartyTransaction3" decimals="-5" unitRef="INR">20000000</in-capmkt:ValueOfTheRelatedPartyTransactionAsApprovedByTheAuditCommittee><in-capmkt:RemarksOnApprovalByAuditCommittee contextRef="D_RelatedPartyTransaction3">Approved by Audit Committee</in-capmkt:RemarksOnApprovalByAuditCommittee><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="D_RelatedPartyTransaction3" decimals="-3" unitRef="INR">13365000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod><in-capmkt:AmountOfRelatedPartyTransaction contextRef="I_RelatedPartyTransaction_PY3" decimals="-3" unitRef="INR">6745000</in-capmkt:AmountOfRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransaction contextRef="I_RelatedPartyTransaction3" decimals="-3" unitRef="INR">5608000</in-capmkt:AmountOfRelatedPartyTransaction><in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_RelatedPartyTransaction4">BIOFIL CHEMICALS AND PHARMACEUTICALS LTD.</in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:PANOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_RelatedPartyTransaction4">******</in-capmkt:PANOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:NameOfCounterParty contextRef="D_RelatedPartyTransaction4">KETAN SHAH</in-capmkt:NameOfCounterParty><in-capmkt:PANOfCounterParty contextRef="D_RelatedPartyTransaction4">******</in-capmkt:PANOfCounterParty><in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary contextRef="D_RelatedPartyTransaction4">Person belong to Promoter and Chairman and Managing Director (KMP) of the Company</in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary><in-capmkt:TypeOfRelatedPartyTransaction contextRef="D_RelatedPartyTransaction4">Remuneration</in-capmkt:TypeOfRelatedPartyTransaction><in-capmkt:ValueOfTheRelatedPartyTransactionAsApprovedByTheAuditCommittee contextRef="D_RelatedPartyTransaction4" decimals="-5" unitRef="INR">3000000</in-capmkt:ValueOfTheRelatedPartyTransactionAsApprovedByTheAuditCommittee><in-capmkt:RemarksOnApprovalByAuditCommittee contextRef="D_RelatedPartyTransaction4">Approved by Audit Committee and also from members</in-capmkt:RemarksOnApprovalByAuditCommittee><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="D_RelatedPartyTransaction4" decimals="-4" unitRef="INR">870000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod><in-capmkt:AmountOfRelatedPartyTransaction contextRef="I_RelatedPartyTransaction_PY4" decimals="-3" unitRef="INR">116000</in-capmkt:AmountOfRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransaction contextRef="I_RelatedPartyTransaction4" decimals="-3" unitRef="INR">116000</in-capmkt:AmountOfRelatedPartyTransaction><in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_RelatedPartyTransaction5">BIOFIL CHEMICALS AND PHARMACEUTICALS LTD.</in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:PANOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_RelatedPartyTransaction5">******</in-capmkt:PANOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:NameOfCounterParty contextRef="D_RelatedPartyTransaction5">APOORV  JAIN</in-capmkt:NameOfCounterParty><in-capmkt:PANOfCounterParty contextRef="D_RelatedPartyTransaction5">******</in-capmkt:PANOfCounterParty><in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary contextRef="D_RelatedPartyTransaction5">Company Secretary and Compliance Officer of the Company</in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary><in-capmkt:TypeOfRelatedPartyTransaction contextRef="D_RelatedPartyTransaction5">Remuneration</in-capmkt:TypeOfRelatedPartyTransaction><in-capmkt:ValueOfTheRelatedPartyTransactionAsApprovedByTheAuditCommittee contextRef="D_RelatedPartyTransaction5" decimals="-5" unitRef="INR">600000</in-capmkt:ValueOfTheRelatedPartyTransactionAsApprovedByTheAuditCommittee><in-capmkt:RemarksOnApprovalByAuditCommittee contextRef="D_RelatedPartyTransaction5">Approved by Audit Committee</in-capmkt:RemarksOnApprovalByAuditCommittee><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="D_RelatedPartyTransaction5" decimals="-4" unitRef="INR">280000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod><in-capmkt:AmountOfRelatedPartyTransaction contextRef="I_RelatedPartyTransaction_PY5" decimals="-3" unitRef="INR">44000</in-capmkt:AmountOfRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransaction contextRef="I_RelatedPartyTransaction5" decimals="-3" unitRef="INR">47000</in-capmkt:AmountOfRelatedPartyTransaction><in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_RelatedPartyTransaction6">BIOFIL CHEMICALS AND PHARMACEUTICALS LTD.</in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:PANOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_RelatedPartyTransaction6">******</in-capmkt:PANOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:NameOfCounterParty contextRef="D_RelatedPartyTransaction6">PAWAN SINGH RAJPUT</in-capmkt:NameOfCounterParty><in-capmkt:PANOfCounterParty contextRef="D_RelatedPartyTransaction6">******</in-capmkt:PANOfCounterParty><in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary contextRef="D_RelatedPartyTransaction6">Chief Financial Officer of the Company</in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary><in-capmkt:TypeOfRelatedPartyTransaction contextRef="D_RelatedPartyTransaction6">Remuneration</in-capmkt:TypeOfRelatedPartyTransaction><in-capmkt:ValueOfTheRelatedPartyTransactionAsApprovedByTheAuditCommittee contextRef="D_RelatedPartyTransaction6" decimals="-5" unitRef="INR">400000</in-capmkt:ValueOfTheRelatedPartyTransactionAsApprovedByTheAuditCommittee><in-capmkt:RemarksOnApprovalByAuditCommittee contextRef="D_RelatedPartyTransaction6">Approved by Audit Committee</in-capmkt:RemarksOnApprovalByAuditCommittee><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="D_RelatedPartyTransaction6" decimals="-4" unitRef="INR">150000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod><in-capmkt:AmountOfRelatedPartyTransaction contextRef="I_RelatedPartyTransaction_PY6" decimals="-3" unitRef="INR">18000</in-capmkt:AmountOfRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransaction contextRef="I_RelatedPartyTransaction6" decimals="-4" unitRef="INR">20000</in-capmkt:AmountOfRelatedPartyTransaction><in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_RelatedPartyTransaction7">BIOFIL CHEMICALS AND PHARMACEUTICALS LTD.</in-capmkt:NameOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:PANOfListedEntityOrSubsidiaryEnteringIntoTheTransaction contextRef="D_RelatedPartyTransaction7">******</in-capmkt:PANOfListedEntityOrSubsidiaryEnteringIntoTheTransaction><in-capmkt:NameOfCounterParty contextRef="D_RelatedPartyTransaction7">Rohan Shah</in-capmkt:NameOfCounterParty><in-capmkt:PANOfCounterParty contextRef="D_RelatedPartyTransaction7">******</in-capmkt:PANOfCounterParty><in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary contextRef="D_RelatedPartyTransaction7">Person belong to Promoter Group of the Company and Relative of KMP</in-capmkt:RelationshipOfTheCounterpartyWithTheListedEntityOrItsSubsidiary><in-capmkt:TypeOfRelatedPartyTransaction contextRef="D_RelatedPartyTransaction7">Remuneration</in-capmkt:TypeOfRelatedPartyTransaction><in-capmkt:ValueOfTheRelatedPartyTransactionAsApprovedByTheAuditCommittee contextRef="D_RelatedPartyTransaction7" decimals="-5" unitRef="INR">1200000</in-capmkt:ValueOfTheRelatedPartyTransactionAsApprovedByTheAuditCommittee><in-capmkt:RemarksOnApprovalByAuditCommittee contextRef="D_RelatedPartyTransaction7">Approved by Audit Committee</in-capmkt:RemarksOnApprovalByAuditCommittee><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="D_RelatedPartyTransaction7" decimals="-5" unitRef="INR">600000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod><in-capmkt:AmountOfRelatedPartyTransaction contextRef="I_RelatedPartyTransaction_PY7" decimals="-3" unitRef="INR">88000</in-capmkt:AmountOfRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransaction contextRef="I_RelatedPartyTransaction7" decimals="-3" unitRef="INR">176000</in-capmkt:AmountOfRelatedPartyTransaction><in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod contextRef="OneD" decimals="-3" unitRef="INR">25585000</in-capmkt:AmountOfRelatedPartyTransactionDuringTheReportingPeriod></xbrli:xbrl>